Scouting report · ASML
Roger J.M. Dassen
Ex-CEO of Deloitte Netherlands; ASML CFO since June 2018
Ranked #11 of 23
Scouting sheet
as of 24 Sep 2026- Age
- 60src
- In the role
- 8 yr
- Promises scored
- 23
- Hit rate
- 87%
- Dodges / 100 answers
- 12.3
- Airtime on calls
- 39%
What to weigh
Watch 3
- Co-presented the 2022 Investor Day plan: the EUR 12.0bn buyback to end-2025 finished at EUR 7.6bn, and the 2025 gross margin target of about 54-56% was withdrawnsrc
- Declined on all three analyst calls reviewed to say how much of the next year's volume is on order, after ASML stopped reporting quarterly bookings from 2026src
- Four outside roles while CFO: De Nederlandsche Bank supervisory board, chair of MUMC+, VU professorship and Mistral AI's Strategic Committeesrc
In their favour 2
Career
- 2018 – nowASML Holdingsrc
EVP & Chief Financial Officer; member of the Board of Management
Joined 2018-06-01 (PR-2018-01-17), succeeding Wolfgang Nickl - 2012 – 2018Deloitte Touche Tohmatsu Limitedsrc
Global Vice Chairman, Risk, Regulatory and Public Policy; Global Chief Ethics Officer; member of the DTTL Executive
Roles from the 2018 release; the 2012 start year comes only from a search summary (WS-deloitte) - 2005 – 2012Deloitte Netherlands (Deloitte Holding B.V.)src
CEO
The 20-F and the 2018 release state the role; the years come only from a search summary (WS-deloitte) - 1996 – 2005Deloitte Netherlandssrc
Audit partner, advisory partner and global lead client service partner for large clients
The release says audit partner since 1996, without an end date
Not located: Before 1996 not located; the 2005 and 2012 boundaries of his Deloitte roles come from a search summary, not a filing
Achievements
- Ran Deloitte in the Netherlands as CEO, then sat on Deloitte's global executive as Vice Chairman for risk, regulatory and public policy and Global Chief Ethics Officersrc
- CFO since June 2018; ASML net sales reached EUR 32.7bn and US GAAP net income EUR 9.61bn in 2025src
- Reappointed for a new four-year term from the 2026 AGM, on the Selection and Nomination Committee's proposalsrc
- Holds 6,643 shares at 2025 year end, 7.81 times base salary against a 3x guidelinesrc
Education
Background
- Family The FY2025 20-F contains no family-relationship statement for the Board of Management (searched); none disclosedsrc
- Boards Member of the Supervisory Board of De Nederlandsche Bank (the Dutch central bank), reported as from 2018-10-01src
- Boards Chair of the Supervisory Board of Maastricht University Medical Center+src
- Boards Joined the Strategic Committee of Mistral AI in 2025, the year ASML invested EUR 1.3bn as lead investor for about 11% fully dilutedsrc
- Other Professor of Auditing at Vrije Universiteit Amsterdam, held alongside his executive rolessrc
- Legal As one of three former Deloitte Netherlands executives he drew an Accountantskamer warning in June 2014 over Deloitte's 2008 dealings with the VEB shareholder group on an Ahold claim; the CBb appeal court overturned it on 2016-09-22src
- Other Serves under a management services agreement, not a Dutch employment contract; severance capped at one year's base salarysrc
The promise ledger
23 scored · 0 open| Result | What was promised | Where it is scored | How |
|---|---|---|---|
| B Beat | Q3 2024 net sales €6.7–7.3bn | ASML row 1 | written outlook |
| M Met | Q3 2024 GM 50–51% | ASML row 2 | written outlook |
| M Met | FY2024 net sales "similar to 2023" (€27,559m) | ASML row 3 | written outlook |
| B Beat | Q4 2024 net sales €8.8–9.2bn | ASML row 4 | written outlook |
| B Beat | Q4 2024 GM 49–50% | ASML row 5 | written outlook |
| M Met | Q1 2025 net sales €7.5–8.0bn | ASML row 6 | written outlook |
| B Beat | Q1 2025 GM 52–53% | ASML row 7 | written outlook |
| M Met | Q2 2025 net sales €7.2–7.7bn | ASML row 8 | written outlook |
| B Beat | Q2 2025 GM 50–53% (band widened for tariffs, PR-Q1-25 note 3) | ASML row 9 | written outlook |
| M Met | Q3 2025 net sales €7.4–7.9bn | ASML row 10 | written outlook |
| M Met | Q3 2025 GM 50–52% | ASML row 11 | written outlook |
| M Met | Q4 2025 net sales €9.2–9.8bn | ASML row 12 | written outlook |
| M Met | Q4 2025 GM 51–53% | ASML row 13 | written outlook |
| M Met | FY2025 net sales €30–35bn | ASML row 14 | written outlook |
| M Met | FY2025 GM 51–53% | ASML row 15 | written outlook |
| M Met | Q1 2026 net sales €8.2–8.9bn | ASML row 16 | written outlook |
| M Met | Q1 2026 GM 51–53% | ASML row 17 | written outlook |
| B Beat | Q2 2026 net sales €8.4–9.0bn | ASML row 18 | written outlook |
| B Beat | Q2 2026 GM 51–52% | ASML row 19 | written outlook |
| M Met | 2025 revenue "between approximately €30 billion and €40 billion" | ASML row 20 | said it, with a colleague |
| W Withdrawn | 2025 GM "between approximately 54% and 56%" | ASML row 21 | said it, with a colleague |
| X Missed | €12.0bn buyback by 2025-12-31 ("We intend to repurchase shares up to an amount of €12.0 billion") | ASML row 22 | said it, with a colleague |
| W Withdrawn | Capacity: "We plan to increase our annual capacity to 90 EUV and 600 DUV systems (2025-2026)" | ASML row 23 | said it, with a colleague |
Questions dodged
12.3 per 100 answersHouri (ODDO BHF) — how much of the 110-unit 2028 scenario is covered by orders → declined by policy: "We're not sharing order intakes. I'm not going to give you the coverage number" (Roger Dassen).
from ASML · dossier-2026-09-24.md
Bouvignies (UBS) — when better Low-NA pricing shows up → answered a different question (it depends on lead times): "That really depends on the order situation that you have with customers." (Roger Dassen). A dodge on timing.
from ASML · dossier-2026-09-24.md
Qiu (Berenberg) — whether ASML outgrows WFE in 2027–28 → "Tammy, as you know, we never comment on WFE." (Roger Dassen). Policy decline.
from ASML · dossier-2026-09-24.md
Sankar (TD Cowen) — bookings run-rate needed to call 2026 a growth year → "Yes, Krish, very nice try. I think some tried this before. We're not going there, right?" (Roger J. M. Dassen).
from ASML · dossier-2026-09-24.md
Metuku (HSBC) — whether ~€6bn of H2 orders sets up a flat 2026 → "I'm not going to give you a grade on your math, Adithya." (Roger J. M. Dassen).
from ASML · dossier-2026-09-24.md
Scemama (BofA) — how much of China's strength is pull-ahead of further restrictions → answered on demand level instead: "And exactly what is driven by considerations by customers, it's very hard to tell." (Roger J. M. Dassen). A dodge.
from ASML · dossier-2026-09-24.md
Sankar (TD Cowen) — bookings run-rate needed for 2026 growth → "In terms of what bookings do we need to get there, I'm not going to go into any detail there." (Roger Dassen), pointing to the backlog instead.
from ASML · dossier-2026-09-24.md
Calls reviewed
FY2025-Q1.roic.json— 21 answers, 36% of the wordsFY2025-Q2.roic.json— 16 answers, 37% of the wordsFY2026-Q2.roic.json— 20 answers, 43% of the words
Sources
10- Filing ASML Holding 20-F for FY2025 (accession 0001628280-26-011378): Board of Management bios, Supervisory Board report, Remuneration report · 2026-02-25
- Filing ASML 6-K, Ex. 99.1 'ASML discloses 2026 AGM results' (0001628280-26-026703) · 2026-04-23
- Filing ASML 6-K, Ex. 99.1 'ASML Announces Appointment of New CFO to the Board of Management' (0001341004-18-000032) · 2018-01-17
- Filing ASML 6-K, Ex. 99.1, 2022 Investor Day release (0001193125-22-282132) · 2022-11-10
- Filing ASML 6-K, Q4 2025 results press release (0001628280-26-003701) · 2026-01-28
- Web search result WebSearch: Roger Dassen CEO Deloitte Nederland 2005-2012, Global Vice Chairman 2012 (summary of results incl. managementscope.nl and Equilar; pages not fetched, egress blocked) · 2026-09-24
- Web search result WebSearch: Roger Dassen appointed to the De Nederlandsche Bank supervisory board as of 2018-10-01 (summary of results; page not fetched) · 2026-09-24
- Web search result WebSearch: CBb overturns Accountantskamer disciplinary warning against Roger Dassen, 2016-09-22 (summary of results; page not fetched) · 2026-09-24
- Call transcript ASML Q1 2025 earnings call (2025-04-16), ROIC.ai
- Call transcript ASML Q2 2026 earnings call (2026-07-15), ROIC.ai